Rachel M Koldej
11PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Dec 11, 2025
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma.Sasanka M Handunnetti, Amit Khot, Piers Blombery
|Jan 24, 2025
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study.Allison Barraclough, Sze Ting Lee, Melinda Burgess
|Oct 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia.Meng-Xiao Luo, Tania Tan, Marie Trussart
|Oct 25, 2024
The economic cost of care in poor graft function following allogeneic stem cell transplantation.Manu Juneja, Ashvind Prabahran, Mayani Rawicki
|Apr 25, 2024
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.Sasanka M Handunnetti, Mary Ann Anderson, Kate Burbury
|Mar 28, 2024
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.Ray Mun Koo, Eric Wong, Joanne E Davis
Pageof 2
Frequent Collaborators
6 joint publications
David S Ritchie
3 joint publications
Ashvind Prabahran
3 joint publications
Stephen Lade
3 joint publications
John F Seymour
3 joint publications
Rodney John Hicks
2 joint publications
Amit Khot
2 joint publications
Lynette Chee
2 joint publications
Mary Ann Anderson
2 joint publications
Sasanka M Handunnetti
2 joint publications
Sarah-Jane Dawson
